Eisai Co., Ltd. (ESAIY) Discusses Value Creation Initiatives, ESG, and Dementia Area Contributions Transcript

Core Points - The meeting aims to discuss Eisai's value creation initiatives and gather feedback for future planning [1] - Eisai emphasizes the social impact of its product LEQEMBI and its contributions to dementia initiatives, which enhance the company's competitiveness [2] Group 1 - The purpose of the Opinion Exchange meeting is to utilize feedback for improving management and future value creation reports [1] - Eisai's initiatives in the dementia area are highlighted as a key source of competitiveness, as detailed in the Value Creation Report 2025 [2] - The company focuses on non-financial capital, including R&D promotion, brand strengthening, and employee engagement, to enhance corporate value [2]